Letter to the Editor - Unenhanced whole-body MRI versus PET-CT for the detection of prostate cancer metastases after primary treatment

Eur Rev Med Pharmacol Sci. 2016 Nov;20(22):4626-4627.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Fluorodeoxyglucose F18
  • Humans
  • Magnetic Resonance Imaging*
  • Male
  • Positron Emission Tomography Computed Tomography*
  • Positron-Emission Tomography
  • Prostatic Neoplasms
  • Radiopharmaceuticals
  • Sensitivity and Specificity
  • Tomography, X-Ray Computed
  • Whole Body Imaging

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18